» Articles » PMID: 28416190

Flow Mediated Dilatation and Progression of Abdominal Aortic Aneurysms

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective/background: Biomarker(s) for prediction of the future progression rate of abdominal aortic aneurysms (AAA) may be useful to stratify the management of individual patients. AAAs are associated with features of systemic inflammation and endothelial dysfunction. Flow mediated dilatation (FMD) of the brachial artery is a recognised non-invasive measurement for endothelial function. We hypothesised that FMD is a potential biomarker of AAA progression and reflects the temporal changes of endothelial function during AAA progression.

Methods: In a prospectively recruited cohort of patients with AAAs (Oxford Abdominal Aortic Aneurysm Study), AAA size was recorded by antero-posterior diameter (APD) (outer to outer) on ultrasound. Annual AAA progression was calculated by (ΔAPD/APD at baseline)/(number of days lapsed/365 days). FMD was assessed at the same time as AAA size measurement. Analyses of data were performed in the overall cohort, and further in subgroups of AAA by size (small: 30-39 mm; moderate: 40-55 mm; large: > 55 mm).

Results: FMD is inversely correlated with the diameter of AAAs in all patients (n=162, Spearman's r=-.28, p<.001). FMD is inversely correlated with AAA diameter progression in the future 12 months (Spearman's r=-.35, p=.001), particularly in the moderate size group. Furthermore, FMD deteriorates during the course of AAA surveillance (from a median of 2.0% at baseline to 1.2% at follow-up; p=.004), while surgical repair of AAAs (n=50 [open repair n=22, endovascular repair n=28)] leads to an improvement in FMD (from 1.1% pre-operatively to 3.8% post-operatively; p<.001), irrespective of the type of surgery.

Conclusion: FMD is inversely correlated with future AAA progression in humans. FMD deteriorates during the natural history of AAA, and is improved by surgery. The utility of FMD as a potential biomarker in the context of AAA warrants further investigation.

Citing Articles

Iron Overload and Abdominal Aortic Aneurysm.

Li Y, Zhou Q, Zhang K, Meng X Rev Cardiovasc Med. 2024; 25(10):361.

PMID: 39484115 PMC: 11522754. DOI: 10.31083/j.rcm2510361.


Myths and methodologies: Cardiopulmonary exercise testing for surgical risk stratification in patients with an abdominal aortic aneurysm; balancing risk over benefit.

Bailey D, Davies R, Rose G, Lewis M, Aldayem A, Twine C Exp Physiol. 2023; 108(9):1118-1131.

PMID: 37232485 PMC: 10988440. DOI: 10.1113/EP090816.


Protective Role for Smooth Muscle Cell Hepcidin in Abdominal Aortic Aneurysm.

Loick P, Mohammad G, Cassimjee I, Chandrashekar A, Lapolla P, Carrington A Arterioscler Thromb Vasc Biol. 2023; 43(5):713-725.

PMID: 36951059 PMC: 10125116. DOI: 10.1161/ATVBAHA.123.319224.


The role of phosphoinositide 3-kinases in immune-inflammatory responses: potential therapeutic targets for abdominal aortic aneurysm.

Zhou H, Wang L, Liu S, Wang W Cell Cycle. 2022; 21(22):2339-2364.

PMID: 35792922 PMC: 9645263. DOI: 10.1080/15384101.2022.2094577.


Endothelial Dysfunction in the Pathogenesis of Abdominal Aortic Aneurysm.

DeRoo E, Stranz A, Yang H, Hsieh M, Se C, Zhou T Biomolecules. 2022; 12(4).

PMID: 35454098 PMC: 9030795. DOI: 10.3390/biom12040509.


References
1.
Hamel M, Henderson W, Khuri S, Daley J . Surgical outcomes for patients aged 80 and older: morbidity and mortality from major noncardiac surgery. J Am Geriatr Soc. 2005; 53(3):424-9. DOI: 10.1111/j.1532-5415.2005.53159.x. View

2.
Sohrabi S, Wheatcroft S, Barth J, Bailey M, Johnson A, Bridge K . Cardiovascular risk in patients with small and medium abdominal aortic aneurysms, and no history of cardiovascular disease. Br J Surg. 2014; 101(10):1238-43. DOI: 10.1002/bjs.9567. View

3.
Anderson T, Meredith I, Yeung A, Frei B, Selwyn A, Ganz P . The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995; 332(8):488-93. DOI: 10.1056/NEJM199502233320802. View

4.
Knipp B, Peterson D, Rajagopalan S, Kehrer C, Ford J, DAlecy L . Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg. 2002; 35(2):363-7. DOI: 10.1067/mva.2002.121069. View

5.
Powell J, Brady A, Brown L, Fowkes F, Greenhalgh R, Ruckley C . Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002; 346(19):1445-52. DOI: 10.1056/NEJMoa013527. View